439
Views
13
CrossRef citations to date
0
Altmetric
Review

The potential role of statins in treating liver disease

ORCID Icon, , , , &
Pages 331-339 | Received 24 Nov 2017, Accepted 07 Feb 2018, Published online: 12 Feb 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Amir Vahedian-Azimi, Sajad Shojaie, Maciej Banach, Farshad Heidari, Arrigo F. G. Cicero, Masoum Khoshfetrat, Tannaz Jamialahmadi & Amirhossein Sahebkar. (2021) Statin therapy in chronic viral hepatitis: a systematic review and meta-analysis of nine studies with 195,602 participants. Annals of Medicine 53:1, pages 1228-1243.
Read now
Antonio Magan-Fernandez, Manfredi Rizzo, Giuseppe Montalto & Giulio Marchesini. (2018) Statins in liver disease: not only prevention of cardiovascular events. Expert Review of Gastroenterology & Hepatology 12:8, pages 743-744.
Read now

Articles from other publishers (11)

Udita Gupta, Thomas Ruli, Danyaal Buttar, Mohamed Shoreibah & Meagan Gray. (2023) Metabolic dysfunction associated steatotic liver disease: Current practice, screening guidelines and management in the primary care setting. The American Journal of the Medical Sciences.
Crossref
P. D. Erokhina, A. A. Slepnev, P. Yu. Mylnikov, S. O. Ganina, E. A. Konyakhin, A. V. Shchulkin & E. N. Yakusheva. (2023) HepG2 cell line as a model for studying of the statins’ hepatic uptake. Experimental and Clinical Gastroenterology:10, pages 70-76.
Crossref
Ambika Choudhary, Ujjawal Rawat, Piyush Kumar & Piyush Mittal. (2023) Pleotropic effects of statins: the dilemma of wider utilization of statin. The Egyptian Heart Journal 75:1.
Crossref
A. E. Bagriy, A. D. Zubov, M. V. Khomenko, E. S. Mikhailichenko, E. A. Pylaeva, N. A. Khaustova & E. V. Bryukhovetskaya. (2021) Patient Management in Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus. Russian Journal of Gastroenterology, Hepatology, Coloproctology 31:2, pages 14-26.
Crossref
Lindsay Meurer & Stanley Martin Cohen. (2020) Drug-Induced Liver Injury from Statins. Clinics in Liver Disease 24:1, pages 107-119.
Crossref
Yue Chang, Qinyu Liu, Zidong Zhou, Yuping Ding, Mei Yang, Wei Xu, Kai Chen, Qing Zhang, Zhenguo Wang & Hai Li. (2020) Can Statin Treatment Reduce the Risk of Hepatocellular Carcinoma? A Systematic Review and Meta-Analysis. Technology in Cancer Research & Treatment 19, pages 153303382093488.
Crossref
Francesco Baratta, Daniele Pastori, Giulia Tozzi, Laura D'Erasmo, Alessia Di Costanzo, Marcello Arca, Evaristo Ettorre, Stefano Ginanni Corradini, Francesco Violi, Francesco Angelico & Maria Del Ben. (2019) Lysosomal acid lipase activity and liver fibrosis in the clinical continuum of non‐alcoholic fatty liver disease. Liver International 39:12, pages 2301-2308.
Crossref
Niloufar Mohammadkhani, Sedigheh Gharbi, Huda Fatima Rajani, Avishan Farzaneh, Golnoosh Mahjoob, Afsaneh Hoseinsalari & Eberhard Korsching. (2019) Statins: Complex outcomes but increasingly helpful treatment options for patients. European Journal of Pharmacology 863, pages 172704.
Crossref
Fabio Nascimbeni, Elisa Pellegrini, Simonetta Lugari, Alberto Mondelli, Serena Bursi, Giovanna Onfiani, Francesca Carubbi & Amedeo Lonardo. (2019) Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foes. Atherosclerosis 284, pages 66-74.
Crossref
Ahmad Hormati, Maryam Jameshorani, Seyed Saeed Sarkeshikian, Mansureh Molaei, Mahdi Jahangiri & Mohammad Reza Ghadir. (2019) Effects of Atorvastatin Alongside Conventional Medical Treatment on Liver Fibrosis and Dysfunction in Patients with Chronic Hepatitis B: A Double-Blinded Clinical Trial. Hepatitis Monthly In Press:In Press.
Crossref
Pakkapon Rattanachaisit, Paweena Susantitaphong, Kessarin Thanapirom, Roongruedee Chaiteerakij, Piyawat Komolmit, Pisit Tangkijvanich & Sombat Treeprasertsuk. (2018) Statin use and histopathological change in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis. Asian Biomedicine 12:1, pages 3-13.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.